News

Affluent Medical announces today the positive conclusion of its OPTIMISE first clinical study for KALIOS, its adjustable mitral repair device. KALIOS has been implanted in five patients between January and May of the current year by Prof. Martin Andreas, Principal Investigator of this feasibility study, at the Vienna General Hospital (AKH). The first results of the study show that the primary endp...

Affluent Medical, a new French medtech player, today announces the postponement of its initial public offering (IPO) to list its shares for trading on the Euronext Growth market in Paris....

On June 7, 2018, the Autorité des marchés financiers (AMF) approved, under number 18-231, the prospectus relating to the IPO of the shares of Affluent Medical, comprising the Document de Base, filed under number I.18-045 on May 28, 2018, and a Note d'Opération (securities note) (including a summary of the prospectus)....

Affluent Medical, a new French medtech player, announces today that it has filed its Document de Base with the Autorité des marchés financiers (AMF) on May 28, 2018, with registration number I. 18-045....